Last checked at 30 Jan 2023 07:00
Tristel plc
("Tristel" or the "Company")
Confirmation of interim results
Investor presentation
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, confirms that its interim results for the six months ended 31 December 2022 will be announced on Monday 20 February 2023.
Analyst briefing
A briefing open to analysts will take place in London on Monday 20 February 2023 at 9.30am. To register and for more details please contact Walbrook PR on tristel@walbrookpr.com
Investor presentation
Paul Swinney, CEO, and Liz Dixon, CFO, will provide a live hybrid presentation relating to the Company's interim results on Monday 20 February 2023 at 4:30pm, which is open to all existing and potential shareholders.
For those attending in-person, the Company welcome them to 85 Gresham Street, London, EC2V 7NQ from 4.15pm for a 4.30pm start and will be followed by refreshments.
For those that are unable to attend, a live webcast of the investor briefing will be broadcast.
If you would like to register to attend in-person, or require the link for the live webcast, please contact Walbrook PR on 020 7933 8787 or email tristel@walbrookpr.com, ensuring you detail in your email if you will attend in-person or online.
The results presentation will be made available on the Company's website on the day of results - www.tristelgroup.com
For further information please contact:
Tristel plc | Tel: 01638 721 500 | |
Paul Swinney, Chief Executive Officer | ||
Liz Dixon, Chief Financial Officer | ||
| ||
Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | |
Paul McManus | Mob: 07980 541 893 | |
Lianne Applegarth | Mob: 07584 391 303 | |
finnCap | Tel: 020 7220 0500 | |
Geoff Nash/ Charles Beeson (Corporate Finance) | ||
Alice Lane (ECM) | ||